Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA)

CUSIP: 05153U107

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+2,116,511
Put/Call ratio
375%
SEC-reported price per share
$7.85
Number of holders
77
Value change
+$16,222,241
Number of buys
46
Open additional details 1 more signal available
Number of sells
25
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,550,724

Security key

05153U107

Report period

Q1 2024

Institutions

77

Top holders

10

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Medicxi Ventures Manageme...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F 3/4/5 Highest disclosed value: $61,336,628 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP has the largest disclosed position value at $61.34M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value Top 5
Medicxi Ventures Management (Jers... $26.93M
Matrix Capital Management Company... $61.34M
EVENTIDE ASSET MANAGEMENT, LLC $51.41M
ADAGE CAPITAL PARTNERS GP, L.L.C. $37.43M
CITADEL ADVISORS LLC $32.17M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Medicxi Ventures Management (Jersey) Ltd
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$26,933,443
3,039,892 shares
— 31 Dec 2023
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$61,336,628
6,922,870 shares
— 31 Dec 2023
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$51,411,763
5,802,682 shares
— 31 Dec 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$37,433,500
4,225,000 shares
— 31 Dec 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$32,173,265
3,631,294 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$18,594,881
2,098,745 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
77
Shares
39,115,323
Rows available
77
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders
116
Q1 2024 holders
77
Holder diff
-39
Investor Q4 2025 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2025 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .